Delivery Order SPE2DB22D3009-SPE2DB25FBB67
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,077.68 for 500 tablets of Doxycycline Hyclate 100 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- On July 21, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,268.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Doxycycline Hyclate 100 mg. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This delivery order represents a routine...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,420.51 firm fixed-price delivery order is for the supply of 4,564,544 units of doxycycline monohydrate 100 mg capsules. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,460.00 with firm fixed pricing and an ultimate completion date of July 24, 2025. The pharmaceutical products will be performed and delivered from the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,248,437 doxycycline 50 mg tablets. The contract, valued at $16,543.56, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania. This delivery order is placed under an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,027.26 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The order is for the supply of 250 units of the pharmaceutical product Doxycycline Mono 100 mg capsules. This delivery order is part of Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA to provide a range of pharmaceutical products and medical supplies to support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,091.90 on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in unit-dose packaging (50-count). This firm fixed-price, competitively awarded contract was funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for ultimate completion by July 23, 2025. The award carries no set-aside designation, reflecting...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,647.33 firm fixed-price contract is for the delivery of 4,564,617,094 units of doxycycline monohydrate 100 mg capsules. The contract has a completion date of May 16, 2024 and is not designated as a set-aside. Amerisourcebergen is a for-profit organization that is registered in the System for Award Management...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $22,645.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 units of doxycycline hyclate 100 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- This is a $3,107.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,567,751,304 units of 50 mg doxycycline tablets, a generic antibiotic medication, with a period of performance through April 1, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBB67Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,136.93 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules in unit-dose packaging of 30 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and completed on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs. The DLA Troop Support Medical supply chain relies on such vendor relationships to maintain pharmaceutical inventory for Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/23/25 |